Results 111 to 120 of about 30,927 (236)

Progressive multi‐focal leucoencephalopathy among ibrutinib‐treated persons with chronic lymphocytic leukaemia [PDF]

, 2016
Charles L. Bennett, Joseph R. Berger, Oliver Sartor, Kenneth R. Carson, William J.M. Hrushesky, Peter Georgantopoulos, Dennis W. Raisch, LeAnn B. Norris, Jamés O. Armitage   +8 more
openalex   +1 more source

Ibrutinib Inhibits Platelet Integrin α _IIb β ₃ Outside-In Signaling and Thrombus Stability But Not Adhesion to Collagen

, 2015
Alexander P. Bye, Amanda J. Unsworth, Sakthivel Vaiyapuri, Alexander R. Stainer, Michael Fry, Jonathan M. Gibbins   +5 more
openalex   +1 more source

ECONOMIC EVALUATION OF IBRUTINIB FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE-CELL LYMPHOMA IN MEXICO [PDF]

, 2016
F. Carlos, M. Zurita Herrera, Aníbal Salazar, Andrew J. Aguirre, L González-Michaca   +4 more
openalex   +1 more source

CLL bei Älteren: Ibrutinib in der Erstlinie bald schon Standard? [PDF]

, 2016
Barbara Kreutzkamp
openalex   +1 more source

The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment. [PDF]

BMC Cancer
Herold S, Schmidt C, Visco C, Tilch MK, Ohler A, Unterhalt M, Hoster E, Hoenig E, Singer S, Tucci A, Pott C, Ladetto M, Hess G, Dreyling M.   +13 more
europepmc   +1 more source

Modelling the Effectiveness of Ibrutinib Versus Rituximab-Based Chemotherapy Regimens in Relapsed/Refractory Mantle Cell Lymphoma [PDF]

, 2016
Simone Critchlow, Dawn Lee, Alizée Latour, Mark Wildgust, Jeffrey L. Goldberg, Simon Rule, M Wang   +6 more
openalex   +1 more source

Integrative green synthesis and molecular simulation of ibrutinib cocrystals for enhanced biopharmaceutical performance and in vivo pharmacokinetics. [PDF]

Int J Pharm X
Kara DD, Bangera PD, Keerikkadu M, Rathnanand M.   +3 more
europepmc   +1 more source

Ibrutinib

Reactions Weekly, 2021
openaire   +1 more source

Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenstrom macroglobulinemia

, 2015
Martin F. M. de Rooij, Annemieke Kuil, Willem Kraan, Marie José Kersten, Steven P. Treon, Steven T. Pals, Marcel Spaargaren   +6 more
openalex   +1 more source

Hepatitis B virus reactivation in patients with hematologic malignancies treated with Bruton tyrosine kinase inhibitors. [PDF]

Blood Res
Hur JY, Lee JH, Lee JH, Park HS, Park H, Choi Y, Choi JH, Won YW, Yoon SE, Kim WS, Kim SJ.   +10 more
europepmc   +1 more source